ADAPT – A Patient Registry of the Real-world Use of Orenitram 2017-12-06T20:54:41+00:00

Clinical Trials

Dec. 6, 2017

ADAPT – A Patient Registry of the Real-world Use of Orenitram

  • Study Sponsor: United Therapeutics
  • Institution: United Therapeutics Corp.
  • Start Date: Tuesday, July 18, 2017
  • End Date: Sunday, June 30, 2019
  • Design: Prospective, observational patient registry
  • Age range (years): 18 Years and older
  • Type of PH
    • All PAH (Group 1 PH)
  • Study Duration for individual patient: 52 weeks
  • Contact: Bucky Turpin, Clinical Project Lead (bturpin@unither.com; 919-425-5492)
  • Listing on clinicaltrials.gov